Resveratrol induces apoptosis in LNCaP cells and requires hydroxyl groups to decrease viability in LNCaP and DU 145 cells
- 22 August 2002
- journal article
- research article
- Published by Wiley in The Prostate
- Vol. 52 (4) , 319-329
- https://doi.org/10.1002/pros.10122
Abstract
BACKGROUND: This study was conducted to determine the effects of resveratrol on prostate cancer cell viability through apoptosis induction and the significance of the three hydroxyl groups on resveratrol to the measured effect.METHODS: Hormone‐sensitive LNCaP cells and hormone‐insensitive DU 145 cells were treated with resveratrol, tri‐methoxy‐resveratrol, or diethylstilbestrol (DES; the positive control for toxicity and apoptosis). Cell viability was determined by using an MTS assay. Apoptosis was determined by the appearance of apoptotic morphology, annexin V‐FITC–positive intact cells, and caspase activation.RESULTS: Resveratrol and DES decreased viability in LNCaP cells, but only resveratrol‐treated cells expressed apoptotic morphology, annexin V‐FITC–positive cells, and caspase activation. Tri‐methoxy‐resveratrol had no effect on DU 145 cell‐viability and was less toxic to LNCaP cells than resveratrol.CONCLUSION: Resveratrol was toxic to cells regardless of whether the cells were hormone‐responsive or ‐unresponsive. This finding suggests that the cell's hormone responsive status is not an important determinant of the response to resveratrol. Furthermore, the hydroxyl‐groups on resveratrol are required for cell toxicity. Finally resveratrol but not DES induced caspase‐mediated apoptosis. Prostate 52: 319–329, 2002.Keywords
This publication has 39 references indexed in Scilit:
- International trends and patterns of prostate cancer incidence and mortalityInternational Journal of Cancer, 2000
- Differential Effects on Growth, Cell Cycle Arrest, and Induction of Apoptosis by Resveratrol in Human Prostate Cancer Cell LinesExperimental Cell Research, 1999
- Cellular interactions in prostate cancerBritish Journal of Urology, 1997
- Resveratrol: A molecule whose time has come? And gone?Clinical Biochemistry, 1997
- Induction of Apoptosis by Diethylstilbestrol in Hormone-Insensitive Prostate Cancer CellsJNCI Journal of the National Cancer Institute, 1996
- Current Concepts in the Treatment of Cancer of the ProstatePublished by Springer Nature ,1996
- Estrogens in the Treatment of Prostate CancerJournal of Urology, 1995
- Apoptosis: Mechanisms and Roles in PathologyPublished by Elsevier ,1991
- A mutation in the ligand binding domain of the androgen receptor of human INCaP cells affects steroid binding characteristics and response to anti-androgensBiochemical and Biophysical Research Communications, 1990
- Diethylstilbestrol in the prevention and treatment of complications of pregnancyAmerican Journal of Obstetrics and Gynecology, 1948